2023 - Revolutionizing Cell and Gene Therapy Trials with Human-Centered Design and Real Patient Narratives

Patient satisfaction and engagement are key to achieving retention and compliance in cell and gene therapy trials, where commitment is crucial, from cell harvesting to ensuring patient involvement in lymphodepletion and study-specific procedures.
Join the featured speakers for an insightful panel discussion on empathetic engagement: a study companion app that transforms the patient experience of these complex cell and gene therapy trials. A concept that combines in-depth therapeutic and operational experience, with engaging, cutting-edge technologies for patients across therapeutic areas. With personalized features, such as direct messaging with study sites, medication and appointment reminders, engaging push notifications and connecting a patient’s support network, study companion apps are creating a seamless and connected journey for patients, from the moment their trial begins.
In collaboration with GRYT Health, a patient panel was conducted, gathering feedback from experienced clinical trial patients who assessed StudyKIK’s oncology app. Discover the remarkable insights gained from participants aged 35 to 76, selected for their demographics and familiarity with adoptive cellular therapies.
Join Greg Christie, Jane Bentley and a member of this patient panel, as they delve into the insights on how use of a study companion app can impact the clinical trial experience for patients who participate in complex oncology trials. This discussion will explore participants’ comfort levels with app usage, their desires, hesitations and invaluable feedback on the user experience.
Don’t miss this exclusive opportunity to register and unlock the true potential of study companion apps, redefining the intricate realm of cell and gene therapy trials and fostering meaningful patient experiences in the world of tech-driven research.